49 related articles for article (PubMed ID: 9876595)
1. Optimization of the processing of matrix pellets based on the combination of waxes and starch using experimental design.
Zhou F; Vervaet C; Massart DL; Massart B; Remon JP
Drug Dev Ind Pharm; 1998 Apr; 24(4):353-8. PubMed ID: 9876595
[TBL] [Abstract][Full Text] [Related]
2. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
3. Investigation on drug dissolution and particle characteristics of pellets related to manufacturing process variables of high-shear granulation.
Dévay A; Mayer K; Pál S; Antal I
J Biochem Biophys Methods; 2006 Nov; 69(1-2):197-205. PubMed ID: 16650480
[TBL] [Abstract][Full Text] [Related]
4. Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique I. Formulation and process variables affecting pellet characteristics.
Cheboyina S; Wyandt CM
Int J Pharm; 2008 Jul; 359(1-2):158-66. PubMed ID: 18499369
[TBL] [Abstract][Full Text] [Related]
5. Preliminary evaluation of an aqueous wax emulsion for controlled-release coating.
Walia PS; Stout PJ; Turton R
Pharm Dev Technol; 1998 Feb; 3(1):103-13. PubMed ID: 9532605
[TBL] [Abstract][Full Text] [Related]
6. Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; Remon JP; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2007 Nov; 67(3):715-24. PubMed ID: 17537625
[TBL] [Abstract][Full Text] [Related]
7. Development and in vitro evaluation of a novel floating multiple unit dosage form obtained by melt pelletization.
Hamdani J; Moës AJ; Amighi K
Int J Pharm; 2006 Sep; 322(1-2):96-103. PubMed ID: 16824707
[TBL] [Abstract][Full Text] [Related]
8. Controlled drug release from Gelucire-based matrix pellets: experiment and theory.
Siepmann F; Muschert S; Flament MP; Leterme P; Gayot A; Siepmann J
Int J Pharm; 2006 Jul; 317(2):136-43. PubMed ID: 16621362
[TBL] [Abstract][Full Text] [Related]
9. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
[TBL] [Abstract][Full Text] [Related]
10. Raman spectroscopy as a process analytical technology tool for the understanding and the quantitative in-line monitoring of the homogenization process of a pharmaceutical suspension.
De Beer TR; Baeyens WR; Ouyang J; Vervaet C; Remon JP
Analyst; 2006 Oct; 131(10):1137-44. PubMed ID: 17003862
[TBL] [Abstract][Full Text] [Related]
11. Matrix mini-tablets based on starch/microcrystalline wax mixtures.
De Brabander C; Vervaet C; Fiermans L; Remon JP
Int J Pharm; 2000 Apr; 199(2):195-203. PubMed ID: 10802413
[TBL] [Abstract][Full Text] [Related]
12. Optimization of melt pelletization in a high shear mixer.
Bukovec P; Kroselj V; Turk S; Vrecer F
Int J Pharm; 2009 Nov; 381(2):192-8. PubMed ID: 19580855
[TBL] [Abstract][Full Text] [Related]
13. Respiratory delivery of theophylline by size-targeted starch microspheres for treatment of asthma.
Momeni A; Mohammadi MH
J Microencapsul; 2009 Dec; 26(8):701-10. PubMed ID: 19888879
[TBL] [Abstract][Full Text] [Related]
14. [Controlled release of pseudoephedrine HCl from pellets].
Vertommen J
Verh K Acad Geneeskd Belg; 1997; 59(6):451-88. PubMed ID: 9543819
[TBL] [Abstract][Full Text] [Related]
15. [Experience in scaling up the film coating process for theophylline sustained-release pellets in mass production].
Grunenberg P; Lorck C; Jünger H; Laicher A
Arzneimittelforschung; 1998 May; 48(5A):547-51. PubMed ID: 9676342
[TBL] [Abstract][Full Text] [Related]
16. Fast dispersible/slow releasing ibuprofen tablets.
Fini A; Bergamante V; Ceschel GC; Ronchi C; de Moraes CA
Eur J Pharm Biopharm; 2008 May; 69(1):335-41. PubMed ID: 18182280
[TBL] [Abstract][Full Text] [Related]
17. Process and formulation variables in the preparation of wax microparticles by a melt dispersion technique. I. Oil-in-water technique for water-insoluble drugs.
Bodmeier R; Wang J; Bhagwatwar H
J Microencapsul; 1992; 9(1):89-98. PubMed ID: 1613647
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
19. Microencapsulation of alpha-tocopherol using sodium alginate and its controlled release properties.
Yoo SH; Song YB; Chang PS; Lee HG
Int J Biol Macromol; 2006 Feb; 38(1):25-30. PubMed ID: 16417917
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
Uhumwangho MU; Okor RS
Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
